Feedback / Questions
AQ280 - LEO Pharma, Aqilion
https://news.cision.com/aqilion/r/aqilion-starts-phase-1-clinical-trial-with-drug-candidate-aq280-for-chronic-inflammatory-diseases,c3612381
Aug 11, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next